Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 845 results for "hcv"

Mahindra flags off 15,000th truck from Chakan plant

Mahindra flags off 15,000th truck from Chakan plant

Mahindra Bus and Truck Division has announced the roll out of its 15,000th Heavy Commercial Vehicle (HCV) from the company's Chakan plant, near Pune, Maharashtra. The company rolled out the Mahindra TRACO 40 from its factory. The 15,000th truck was ..., 3 days ago

Ashok Leyland a good bet, to benefit from volume growth in M&HCV segment: Mayuresh Joshi

, shares his views on prospects held by Ashok Leyland. Excerpts: ET Now: Is Ashok Leyland pricing in a lot of benefits right now? What are the numbers that you are working with for Ashok Leyland and would you go out and recommend people to buy into this one? ...
 Economic Times2 days ago Indian M&HCV industry to touch 385,000 units by 2020  MotorIndia6 days ago Ashok Leyland's M&HCV sales up by 53 % in July  Smart Investor4 weeks ago Ashok Leyland's M&HCV June sales up by 46%  Business Standard1 month ago
Financial Express

Ashok Leyland M&HCVs capture 35% market share on strong demand

Ashok Leyland has acquired 35% market share in the medium and heavy commercial vehicle (M&HCV) segment in July on the back of a strong demand, expansion of the dealership network in the north and east India and high discounts on vehicles. This ...
 Financial Express1 week ago Ashok Leyland sets out to reclaim LCV mkt share  Deccan Herald1 month ago
Bidness Etc

Gilead Sciences, Inc. Astonishing Performance In HCV Market

Gilead Sciences, Inc. ( NASDAQ:GILD ) has outperformed AbbVie Inc. ( NYSE:ABBV ) with its hepatitis C virus (HCV) drugs prescription data since December 2014, when AbbVie launched its own version of HCV drug, Viekira Pak. Gilead launched its ...
 Bidness Etc1 week ago Gilead Sciences, Inc. (GILD) HCV Prescriptions And Impact On Earnings  Bidness Etc1 month ago Take A Look At Gilead Sciences  Investing.com1 day ago Gilead Sciences, Inc. Harvoni Vs. AbbVie Inc Humira: Which Would Be Best-Selling Drug Of 2015?  Bidness Etc4 days ago

Daclatasvir plus sofosbuvir cures HCV for most people with HIV and HCV co-infection in French compassionate use programme

Interferon-free treatment using daclatasvir ( Daklinza ) and sofosbuvir ( Sovaldi ), with or without ribavirin, was well-tolerated and produced sustained virological response rates of 95-100% for people with HIV and HCV co-infection and advanced ...
 Aidsmap3 weeks ago Bristol-Myers Squibb's Daklinza receives US FDA approval to treat HCV genotype 3 infections  PharmaBiz1 month ago Chronic HCV genotype 3 drug approved  Pharmacist.com1 month ago FDA approves Daklinza for the treatment of HCV genotype 3  European Pharmaceutical Review1 month ago
European Pharmaceutical Review

FDA approves new cholesterol drug - at $14,600 a year

[from Jules: this is much more costly to healthcare system than HCV drugs, this drug is taken forever for up to 10 million people. I donÕt see the federal govt or medicaid restricting this yet] 7:26 p.m. EDT July 24, 2015 ...
 National AIDS Treatment Advocacy Project1 month ago Two New HCV Treatments Approved  ASHP1 month ago Public at risk due to current medical practices for the detection of hepatitis C infection  Medical News Today1 month ago Breakthrough Hep C Development Announced  Occupational Health & Safety1 month ago
Autocar Professional

M&HCV sales in India stick to the growth path in July

Carrying forwarding the momentum of the past 11 months, the medium and heavy commercial vehicle (M&HCV) segment registered positive sales numbers during the month. All the major CV OEMs maintained a strong performance in the M&HCV segment, thanks ...
 Autocar Professional4 weeks ago M & HCV business to grow by 12 per cent  Asian Age2 months ago

The Cure for Gilead

Gilead has the cure for Hepatitis C (HCV) known as Sofosbuvir, which is taken alone or in combination with other drugs. Now we need a cure for Gilead. By pressing the company to make Sofosbuvir-based therapies accessible to all who need them, the ...
 Huffington Post3 weeks ago

New HCV drugs are cheaper, much more effective: Dr Anil Arora

Q&A with the Chairman-Director of Institute of Liver Gastroenterology and Pancreatico Bilary Sciences, Sir Ganga Ram Hospital Namit Gupta | Mumbai August 1, 2015 Last Updated at 17:36 IST While the disease is a slow killer, Hepatitis C can lead to chronic ...
 Business Standard4 weeks ago

Gilead Sciences, Inc. Rules 95% Of The HCV Market

Gilead Sciences, Inc. ( NASDAQ:GILD ) currently rules the US HCV market with around 95% market share, leaving its rival, AbbVie Inc ( NYSE:ABBV ), far behind in the race, according to Symphony Health Data used by Bloomberg Intelligence. ...
 Bidness Etc4 weeks ago NJIT Alumnus Joins Executive Board of Gilead Sciences, Inc.  Noodls4 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - hcv
Get updated on latest news & your favorite topics right in your inbox!
More     Less